drug
patiromer sorbitex calcium
Marketedupdated 5mo agoby Vifor Pharma Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying patiromer sorbitex calcium
- phase4Potassium Correction for RAAS Optimization in Chronic Kidney Disease
- phase3Patiromer Trial in CKD Stage IIIB to V
- —Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia
- phase4Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 14, 2027
153 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (28)
- Oct 8, 2033method-of-use (U-1766)US 11123363
- Oct 8, 2033method-of-use (U-1766)US 11123363
- Oct 8, 2033method-of-use (U-1766)US 11123363
- Oct 8, 2033method-of-use (U-1766)US 11123363
- Oct 8, 2033method-of-use (U-1766)US 9492476
- Oct 8, 2033method-of-use (U-1766)US 9492476
- Oct 8, 2033method-of-use (U-1766)US 9492476
- Oct 8, 2033method-of-use (U-1766)US 9492476
- Oct 8, 2033method-of-use (U-1766)US 9925212
- Oct 8, 2033method-of-use (U-1766)US 9925212
- Oct 8, 2033method-of-use (U-1766)US 9925212
- Oct 8, 2033method-of-use (U-1766)US 9925212
- May 29, 2030compositionUS 83378243.6y
- May 29, 2030compositionUS 83378243.6y
- May 29, 2030compositionUS 83378243.6y
- May 29, 2030compositionUS 83378243.6y
- Jun 20, 2028formulationUS 81478731.7y
- Jun 20, 2028formulationUS 81478731.7y
- Jun 20, 2028formulationUS 81478731.7y
- Jun 20, 2028formulationUS 81478731.7y
- May 29, 2027formulationUS 8282913229d
- May 29, 2027formulationUS 8282913229d
- May 29, 2027formulationUS 8282913229d
- May 29, 2027formulationUS 8282913229d
- Mar 14, 2027method-of-use (U-1766)US 8216560153d
- Mar 14, 2027method-of-use (U-1766)US 8216560153d
- Mar 14, 2027method-of-use (U-1766)US 8216560153d
- Mar 14, 2027method-of-use (U-1766)US 8216560153d
FDA exclusivities (4)
- Oct 2, 2026NPPNew Product (3y)
- Oct 2, 2026NPPNew Product (3y)
- Oct 2, 2026NPPNew Product (3y)
- Oct 2, 2026NSNS
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 52m ago
Found something off?
comments(0)
5-min edit window · permanent after that